期刊文献+

适形放疗、同步化疗加羟基喜树碱热灌注化疗治疗晚期膀胱癌的临床疗效观察 被引量:4

下载PDF
导出
摘要 目的探讨适形放疗、同步化疗加羟基喜树碱热灌注化疗治疗晚期膀胱癌的临床疗效。方法将48例晚期膀胱癌患者按就诊顺序随机分为两组,每组各24例,其中对照组采取适形放疗+同步化疗(吉西他滨+表阿霉素),观察组在此基础上加用羟基喜树碱热灌注化疗,比较两组临床疗效及不良反应发生情况。结果观察组有效率为79.17%,显著高于对照组的58.33%(P<0.05);两组不良反应发生率比较差异无统计学意义(P>0.05)。结论适形放疗、同步化疗加羟基喜树碱热灌注化疗治疗晚期膀胱癌疗效确切,不良反应可耐受,值得临床推广和应用。
出处 《中国现代药物应用》 2014年第9期114-115,共2页 Chinese Journal of Modern Drug Application
  • 相关文献

参考文献2

二级参考文献9

  • 1Hussain SA,James ND.The systemic treatment of advanced and metastatic bladder cancer[J].Lancet Oncol,2003,4:489-497.
  • 2Shrod SS,Faucette SR,Gillenwater HH,et al.Gemcitabine pharmacokinetics and interaction with paclitaxel in patients with dvanced non-small-cell lung cancer[J].Cancer Chemother Pharmacol,2003,51:328.
  • 3Khaled HM,Zaqhloul MS,Ghoneim M,et al.A randomized phase Ⅲ study of neoadjuvant chemotherapy for invasive bladder cancer with gemcitabine and cisplatin[J].Proc Ann Meet Am Soc Clin Oncol,2002,21:A2421.
  • 4赵新汉,张晓智,常柏玲,等.肿瘤多学科综合治疗[M].西安:第四军医大学出版社,2007:626-627.
  • 5Choy H.Combination chemoradiotherapy with Gemcitabine:potential applications[J].Oncology(Huntingt),2000;14(7 S 4):20-5.
  • 6Wu Kl,Jiang Gl,Liao Y,et al.A phase I study of gemicitabine with concurrent radiotherapy in stage Ⅲ,locally advanced non-small cell lung cancer[J].Clin Cancer Res,2003;9(7):2472.
  • 7周际昌.实用肿瘤内科学[M].北京:人民卫生出版社,2002.45~48.
  • 8孙燕,赵平.临床肿瘤学进展[M].北京:中国协和医科大学出版社,2006:602-603.
  • 9薛圣留,潘宏铭.晚期膀胱癌的化疗进展[J].国外医学(泌尿系统分册),2004,24(3):350-354. 被引量:3

共引文献8

同被引文献55

  • 1潘显道,王存英.天然抗肿瘤药喜树碱衍生物的研究进展[J].药学学报,2003,38(9):715-720. 被引量:31
  • 2陶逸然,金讯波,王慕文,赵勇,于潇.吉西他滨联合顺铂新辅助化疗治疗肌层浸润性膀胱癌的临床疗效观察[J].泌尿外科杂志(电子版),2014,6(2):23-28. 被引量:12
  • 3周浴,李云飞,张少峰,等.辅助性吉西他滨膀胱灌注治疗高危非肌层浸润性膀胱癌的临床研究[J].中华临床医师杂志(电子版),2013;20(20):9162-5.
  • 4Baumann BC, Guzzo T, Vaughn D, et al. Bladder cancer patterns of pelvic failure implications for adjuvant radia- tion therapy[J]. Int J Radiat Oncol Biol Phys, 2011,81 (2) .. $72-$73.
  • 5Azria D, Riou O, Rebillard X, et al. Combined chemoradi-ation therapy with twice-weekly gemcitabine and cisplatin for organ preservation in muscle-invasive bladder cancer: long-term results of a phase 1 trial[J]. Int J Radiat Oncol Biol Phys, 2014,88 (4) : 853-859.
  • 6Turgeon GA, Souhami L, Cury FL, et al. Hypofractionat- ed intensity modulated radiation therapy in combined mo- dality treatment for bladder preservation in elderly pa- tients with invasive bladder cancer[J]. Int J Radiat Oneoi Biol Phys,2014,88(2) :326 331.
  • 7Ghadjar P, Zelefsky MJ, Spratt DE, et al. Impact of dose to the bladder trigone on long-term urinary function after high-dose intensity modulated radiation therapy for local- ized prostate cancer[J]. Int J Radiat Oneol Biol Phys, 2014,88 (2) 339-344.
  • 8Huddart AR. Randomized noninferiority trim of reduced high-dose volume versus standard volume radiation thera- py for muscle-invasive bladder cancer: Results of the BC2001 Trial(CRUK/01/004)[J]. Int J Radiat Oncol Bi- ol Phys,2013,87(2) ..261-269.
  • 9Aluwini S, Van Rooij P H,Kirkels W J, et al. Bladder func- tion preservation with brachytherapy,external beam radi- ation therapy, and limited surger in bladder cancer pa- tients: Long-Term results [J]. Int J Radiat Oncol Biol Phys,2014,88(3) ..611-617.
  • 10Coen JJ,Paly JJ, Niemierko A, et al. Nomograms predic- ting response to therapy and outcomes after BladdevPre- serving trimodality therapy for muscle-invasive bladder cancer[J]. Int J Radiat Oncol Biol Phys, 2013,86 (2) : 311- 316.

引证文献4

二级引证文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部